Garuda Wins Big: Revolutionizing Stem Cell Therapy
![BioTech Breakthrough Awards](https://nationalstemcelltherapy.com/wp-content/uploads/2023/11/biotech-breakthrough-awards-badge1-copy.jpg)
Garuda Therapeutics has been honored with the prestigious title of “Overall Cell Biology Company of the Year” by BioTech Breakthrough, an independent organization that recognizes top performers in the life sciences and biotechnology sectors. This accolade was awarded to Garuda for their innovative approach to creating off-the-shelf hematopoietic stem cell (HSC) therapies. These therapies are […]
Exploring the Different Types of Stem Cells Found in Bone Marrow
![stem cells found in bone marrow](https://nationalstemcelltherapy.com/wp-content/uploads/2023/08/stem-cells-found-in-bone-marrow-1024x683.png)
Imagine a bustling city where every individual has a unique job to do. Some are builders, some are healers, and some are protectors. This city is like our body, and the individuals? They’re our cells. Now, there’s a special group in this city, the jack-of-all-trades, ready to become any professional needed. These are our stem […]
Clinical Applications of Hematopoietic Stem Cells in Blood Cell Disorders
![illustration of human body blood system](https://nationalstemcelltherapy.com/wp-content/uploads/2023/06/illustration-of-human-body-blood-system-1024x683.png)
Welcome, dear readers, to our exploration of the fascinating world of stem cells. Today, we’re diving deep into a specific type of stem cell, known as the hematopoietic stem cell. Picture these cells as the master builders of our blood system, the architects that design and construct the various types of cells that flow through […]
The Miracle of Birth Just Got Even More Miraculous: Discover the Lifesaving Potential of Cord Blood Banking!
![newborn baby representing the power of cord blood stem cells](https://nationalstemcelltherapy.com/wp-content/uploads/2023/05/newborn-baby-representing-the-power-of-cord-blod-stem-cells-1024x683.png)
Hello there, future parents! Congratulations on the upcoming addition to your family. There’s a lot to think about when you’re expecting, isn’t there? From choosing the right stroller to deciding on the color of the nursery. But today, let’s chat about something a bit more scientific, yet equally important – umbilical cord blood banking and […]
The Quest for Stem Cells: Discovering Where They Come From
![where do stem cells come from](https://nationalstemcelltherapy.com/wp-content/uploads/2023/03/where-do-stem-cells-come-from-1024x576.jpg)
This short video explains that stem cells are special cells that can develop into different types of cells, and are found in all organisms, including plants, animals, and humans. Human stem cells can come from infant stem cells or adult stem cells. Embryonic stem cells come from blastocysts, which are formed about 5-6 days after […]
Beam Therapeutics Enrolls First Patient in BEACON Clinical Trial of BEAM-101 Base Editing Therapy Candidate for the Treatment of Sickle Cell Disease
![Beam Therapeutics logo](https://nationalstemcelltherapy.com/wp-content/uploads/2022/11/beam-therapeutics-logo-1024x525.jpg)
CAMBRIDGE, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the first patient has been enrolled in the company’s BEACON trial. BEACON is an open-label, single-arm, multicenter, Phase 1/2 clinical trial designed to evaluate the safety and efficacy of BEAM-101 in […]
Orchard Announces Multiple Presentations at 2022 ESGCT Annual Congress Showing the Potential of HSC Gene Therapy in Several Therapeutic Areas
![Orchard Therapeutics](https://nationalstemcelltherapy.com/wp-content/uploads/2022/05/orchard-therapeutics-logo.png)
BOSTON and LONDON, Oct. 10, 2022 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced multiple presentations at the 29th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT), taking place October 11-14, 2022, in Edinburgh. Clinical and pre-clinical data from across the company’s hematopoietic stem cell […]
Orchard Therapeutics Announces Multiple Presentations at 2022 SSIEM Annual Symposium Highlighting Neurometabolic Disease Portfolio
![Orchard Therapeutics](https://nationalstemcelltherapy.com/wp-content/uploads/2022/05/orchard-therapeutics-logo.png)
BOSTON and LONDON, Aug. 29, 2022 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced seven presentations from across its neurometabolic portfolio will be featured at the Society for the Study of Inborn Errors of Metabolism (SSIEM) Annual Symposium, taking place from August 30 to September 2, 2022, in Freiburg, […]
Stem Cell Assays Market Report 2022-2027: Government Initiatives to Boost Stem Cell Research Present Opportunities
![Research and Markets Logo](https://nationalstemcelltherapy.com/wp-content/uploads/2022/07/Research_and_Markets_Logo.jpg)
DUBLIN, July 7, 2022 /PRNewswire/ — The “Stem Cell Assays Market by Type (Viability, Proliferation, Differentiation, Apoptosis), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instrument), Application (Regenerative Medicine, Clinical Research), End User – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The stem cell assay market is projected to reach […]
Animal Stem Cell Therapy Market projected CAGR of 5.2% for the next ten years (2022-2032) – Persistence Market Research
![Persistence Market Research logo](https://nationalstemcelltherapy.com/wp-content/uploads/2022/06/Persistence-Market-Research-logo-1024x622.jpg)
New York, June 27, 2022 (GLOBE NEWSWIRE) — The global animal stem cell therapy market recorded sales of around US$ 249.9 Mn in 2021 and the market is predicted to experience healthy growth over the years ahead at a CAGR of 5.2% (2022 to 2032). Animal stem cell therapies are treatments for disorders such as […]